Breast cancer in Brazil: epidemiology and treatment challenges

References

• Instituto Brasileiro de Geografia e Estatística (IBGE)Escassez e Fartura: Distribuição da Oferta de Equipamentos de Diagnóstico por Imagem no Brasil [Scarcity and abundance: distribution of supply diagnostic imaging equipment in Brazil]Rio de JaneiroIBGE2009 [cited February 14, 2013]. Available from: http://www.ibge.gov.br/home/estatistica/populacao/indic_sociosaude/2009/com_esca.pdfAccessed August 2, 2014 Portuguese
   Google Scholar
• Ministério da Saúde. Secretaria ExecutivaSUS: Princípios e Conquistas [SUS: Principles and Achievements]BrasíliaMinistério da Saúde2000 Available from: http://bvsms.saude.gov.br/bvs/publicacoes/sus_principios.pdfAccessed August 4, 2014 Portuguese
   Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• LeeBLLiedkePEBarriosCHSimonSDFinkelsteinDMGossPEBreast cancer in Brazil: present status and future goalsLancet Oncol2012133e95e10222381937
   PubMed Web of Science ®Google Scholar
• AzevedoGMendonçaSCancer in the female population in BrazilRev Saude Publica19932716875 Portuguese8310272
   PubMedGoogle Scholar
• MoraesMFA mortalidade por câncer de mama no Brasil [Mortality from breast cancer in Brazil]Revista Brasileira de Cancerologia1998442 Portuguese
   Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• DATASUS [database on the Internet]Ministério da Saúde2008 Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=01Accessed July 28, 2014 Portuguese
   Google Scholar
• SISMAMASistema de Informação do Controle do Câncer de Mama – manual gerencial [Information Systems for Control of Breast Cancer – Manual Management]. Equipe de Elaboração: Maria Beatriz Kneipp DiasRio de JaneiroBrazillian Ministry of Health Available from: http://www2.inca.gov.br/wps/wcm/connect/cancermama/site/home/sismamaAccessed July 28, 2014 Portuguese
   Google Scholar
• PrataPRA transição epidemiológica no Brasil [The epidemiologic transition in Brazil]Cad Saude Publica19928168175 Portuguese
   Google Scholar
• DollRAre we winning the fight against cancer? An epidemiological assessment. EACR – Mühlbock memorial lectureEur J Cancer1990265005082141517
   PubMed Web of Science ®Google Scholar
• HerreraACPanisCVictorinoVJMolecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patientsCancer Immunol Immunother2012612193220122618884
   PubMed Web of Science ®Google Scholar
• PanisCVictorinoVJHerreraACDifferential oxidative status and immune characterization of the early and advanced stages of human breast cancerBreast Cancer Res Treat201213388188822048816
   PubMed Web of Science ®Google Scholar
• PanisCLemosLGVictorinoVJImmunological effects of taxol and adryamicin in breast cancer patientsCancer Immunol Immunother20126148148821959683
   PubMed Web of Science ®Google Scholar
• PanisCHerreraACVictorinoVJOxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapyBreast Cancer Res Treat2012133899721811816
   PubMed Web of Science ®Google Scholar
• PanisCHerreraACVictorinoVJAranomeACecchiniRScreening of circulating TGF-β levels and its clinicopathological significance in human breast cancerAnticancer Res20133373774223393376
   PubMed Web of Science ®Google Scholar
• AdamiHOHunterDTrichopoulosDTextbook of Cancer Epidemiology2nd edOxfordOxford University Press2008
   Google Scholar
• DuflothRMCarvalhoSHeinrichJKAnalysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family historySao Paulo Med J2005123419219716389418
   PubMedGoogle Scholar
• EwaldIPIzettiPVargasFRPrevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndromeHered Cancer Clin Pract201191222185575
   PubMed Web of Science ®Google Scholar
• KoifmanSKoifmanRJEnvironment and cancer in Brazil: an overview from a public health perspectiveMutat Res20035442–330531114644332
   PubMed Web of Science ®Google Scholar
• RichardsMASmithPRamirezAJFentimanISRubensRDThe influence on survival of delay in the presentation and treatment of symptomatic breast cancerBr J Cancer19997985886410070881
   PubMed Web of Science ®Google Scholar
• SimonSDBinesJBarriosCHClinical characteristics and outcome of treatment of Brazilian women with breast cancer treated at public and private institutions – the AMAZONE project of the Brazilian breast cancer study group (GBECAM)Abstracts of the 2009 CTRC-AACR San Antonio Breast Cancer SymposiumDecember 9–13, 2009San Antonio, TX Suppl to volume 69, Issue 24 of Cancer Research
   Google Scholar
• Instituto Nacional de CâncerControle do Câncer de Mama: fatores de risco [Breast cancer control: risk factors] [webpage on the Internet]Rio de JaneiroMinistério da Saúde Available from: http://www2.inca.gov.br/wps/wcm/connect/acoes_programas/site/home/nobrasil/programa_controle_cancer_mama/fatores_riscoAccessed July 28, 2014 Portuguese
   Google Scholar
• Lima-CostaMFMatosDLPrevalence and factors associated with mammograms in the 50–69-year age group: a study based on the Brazilian National Household Sample Survey (PNAD-2003)Cad Saude Publica20072316651673 Portuguese17572816
   PubMed Web of Science ®Google Scholar
• BoylePLevinBWorld Cancer Report 2008LyonInternational Agency for Research on Cancer2008 Available from: http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/Accessed August 15th, 2014
   Google Scholar
• AndersonBOCazapEEl SaghirNSOptimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010Lancet Oncol20111238739821463833
   PubMed Web of Science ®Google Scholar
• FIOCRUZ – Cobertura de mamografia – PROADESSII – Fiocruz2011 Available from: http://www.proadess.icict.fiocruz.br/index.php?pag=fic&cod=A07&tab=1Accessed August 2, 2014 Portuguese
   Google Scholar
• FreitasRFRahalRMSRodriguesDCNDados sobre produção de mamografias no Brasil, em 2012 e 2013 e número de mamógrafos em uso em 2013 [Data regarding mammograms in Brazil, between 2012 and 2013, and the number of mammographs]. Fevereiro de 2014 Available from: http://www.sbmastologia.com.br/index/index.php/component/content/article/50-destaque-medico/321-dados-sobre-producaoAccessed July 28, 2014 Portuguese
   Google Scholar
• Portaria n.° 1101/GM [Ordinance No 1101 / GM]BrasíliaMinistério da Saúde2002 Available from: http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2002/Gm/GM-1101.htmAccessed November 19, 2014 Portuguese
   Google Scholar
• LaurentiRTransição demográfica e transição epidemiológica [Demographic and epidemiologic transition]Anais do 1° Congresso Brasileiro de Epidemiologia1990 set 2–6Campinas, BrasilRio de JaneiroAbrasco1990143165 Portuguese
   Google Scholar
• AlbalaCVioFYanezMTransición epidemiológica en América Latina: comparación de cuatro países [Epidemiological transition in Latin America: comparison of 4 countries]Rev Med Chil19971256719727 Portuguese9580335
   PubMedGoogle Scholar
• BaracatFFde LimaGRde OliveiraABBaracatFBaracatFInflammatory carcinoma of the breast. Experience of 43 cases at the Instituto do Câncer Arnaldo Vieira de CarvalhoRev Paul Med198810611420 Portuguese3238260
   PubMedGoogle Scholar
• SchwartsmannGMansDRMenkeCHA phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancerOncology (Williston Park)1997114 Suppl 324299144687
   PubMedGoogle Scholar
• MuradAMGuimaraesRCAmorimWCMoriciACFerreira-FilhoAFSchwartsmannGPhase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancerBreast Cancer Res Treat199745147539285116
   PubMed Web of Science ®Google Scholar
• MuradAMGuimarãesRCAragãoBCScalabrini’NetoAORodriguesVHGarciaRGemcitabine and paclitaxel as salvage therapy in metastatic breast cancerOncology (Williston Park)2001152 Suppl 3252711252885
   PubMed Web of Science ®Google Scholar
• HeggRCostaMAPerdicarisMA phase II trial of fractionated vinorelbine/doxorubicin as first line therapy for advanced breast cancerCurr Med Res Opin200116422523411268706
   PubMed Web of Science ®Google Scholar
• CostaLJVarellaPCdel GiglioAWeight changes during chemotherapy for breast cancerSao Paulo Med J2002120411311712436158
   PubMedGoogle Scholar
• AnelliABrentaniRRGadelhaAPAmorim De AlbuquerqueASoaresFCorrelation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancerAnn Oncol200314342843212598349
   PubMed Web of Science ®Google Scholar
• PiatoJRBarrosACPinceratoKMSampaioAPPinottiJASentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot studyEur J Surg Oncol200329211812012633552
   PubMedGoogle Scholar
• GianniLPienkowskiTImYHEfficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trialLancet Oncol2012131253222153890
   PubMed Web of Science ®Google Scholar
• Ministério da Saúde (Br). Secretaria de Atenção à SaúdeControle dos Cânceres do Colo do Útero e da Mama [Control of breast and uterine cancers]BrasíliaMinistério da Saúde2014 Portuguese
   Google Scholar
• Ministério da Saúde (Br). Secretaria de Atenção à SaúdeControle dos Cânceres do Colo do Útero e da Mama [Control of breast and uterine cancers]BrasíliaMinistério da Saúde2006 Portuguese
   Google Scholar